Nuclear Regulation Implications of Gene Therapy in Dentistry and Periodontics: A … – Cureus Carmen Lillard Nov 26, 2023 Implications of Gene Therapy in Dentistry and Periodontics: A ... Cureus
Nuclear Regulation Death after High-Dose rAAV9 Gene Therapy in a Patient with … – nejm.org Carmen Lillard Sep 28, 2023 Death after High-Dose rAAV9 Gene Therapy in a Patient with ... nejm.org
Nuclear Regulation Metabolic challenges and interventions in CAR T cell therapy – Science Carmen Lillard Apr 15, 2023 Metabolic challenges and interventions in CAR T cell therapy Science
Nuclear Regulation Proton boron capture therapy (PBCT) induces cell death and … – Nature.com Carmen Lillard Apr 9, 2023 Proton boron capture therapy (PBCT) induces cell death and ... Nature.com
Nuclear Regulation Targeted Therapy for NSCLC | PGPM – Dove Medical Press Carmen Lillard Oct 1, 2021 Targeted Therapy for NSCLC | PGPM Dove Medical Press
Nuclear Regulation Gene therapy with the AR isoform 2 saves the phenotype of spinal and bulbar muscle atrophy by… Carmen Lillard Aug 21, 2021 Gene therapy with AR isoform 2 rescues the phenotype of spinal and bulbar muscular atrophy by modulating AR transcription activity
Nuclear Regulation A theranostic platform for synergetic cancer therapy | IJN – Dove Medical Press Carmen Lillard Jul 30, 2021 A theranostic platform for synergetic cancer therapy | IJN Dove Medical Press
Nuclear Regulation Human Tumor Microenvironment Chip Evaluates Consequences of Platelet Extravasation and Combined… Carmen Lillard Jul 22, 2021 Human Tumor Microenvironment Chip Evaluates Consequences of Platelet Extravasation and Combinatorial Antitumor-Antiplatelet Therapy in Ovarian Cancer. Scientific Advances
Nuclear Regulation Mapping of m6A and its regulatory targets in prostate cancer shows low METTL3 induction of therapy… Carmen Lillard Jun 6, 2021 Mapping of m6A and its regulatory targets in prostate cancer shows a low METTL3 induction of therapy resistance DocWire News
Nuclear Regulation Mapping of m6A and its regulatory targets in prostate cancer shows low METTL3 induction of therapy… Carmen Lillard Jun 6, 2021 Mapping of m6A and its regulatory targets in prostate cancer shows a low METTL3 induction of therapy resistance DocWire News